1. Home
  2. PROP vs NSRX Comparison

PROP vs NSRX Comparison

Compare PROP & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prairie Operating Co.

PROP

Prairie Operating Co.

N/A

Current Price

$0.31

Market Cap

44.9M

Sector

Finance

ML Signal

N/A

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.60

Market Cap

37.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PROP
NSRX
Founded
2001
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.9M
37.1M
IPO Year
2008
2024

Fundamental Metrics

Financial Performance
Metric
PROP
NSRX
Price
$0.31
$2.60
Analyst Decision
Buy
Buy
Analyst Count
2
3
Target Price
$1.50
★ $16.50
AVG Volume (30 Days)
★ 1.2M
13.6K
Earning Date
11-12-2026
08-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 49.06
N/A
EPS
N/A
★ N/A
Revenue
★ $7,939,000.00
N/A
Revenue This Year
$85.81
N/A
Revenue Next Year
$11.47
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 413.59
N/A
52 Week Low
$0.30
$1.98
52 Week High
$2.55
$9.50

Technical Indicators

Market Signals
Indicator
PROP
NSRX
Relative Strength Index (RSI) 36.77 35.60
Support Level N/A $2.41
Resistance Level $0.44 $3.61
Average True Range (ATR) 0.05 0.20
MACD -0.01 -0.03
Stochastic Oscillator 2.94 21.47

Price Performance

Historical Comparison
PROP
NSRX

About PROP Prairie Operating Co.

Prairie Operating Co is an independent oil and natural gas company focused on the acquisition and development of crude oil, natural gas, and natural gas liquids (NGLs). Its assets and operations are located in the oil region of rural Weld County, Colorado, within the Denver-Julesburg Basin in Colorado (the DJ Basin). The company generates maximum revenue from crude oil sales, and the rest from the sale of natural gas and natural gas liquids.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: